Improve Medical released its performance for the first three quarters, with a net profit attributable to the parent company of 24.0441 million yuan, an increase of 156.55%
Improve Medical released its Q3 2025 report, with operating revenue for the first three quarters at 349 million yuan, a year-on-year decrease of 17.14%. The net profit attributable to the parent company was 24.0441 million yuan, a year-on-year increase of 156.55%; the net profit excluding non-recurring gains and losses was 30.3577 million yuan, a year-on-year increase of 325.04%. The basic earnings per share were 0.08 yuan
According to the Zhitong Finance APP, Improve Medical (300030.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 349 million yuan, a year-on-year decrease of 17.14%. The net profit attributable to shareholders of the listed company was 24.0441 million yuan, a year-on-year increase of 156.55%. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 30.3577 million yuan, a year-on-year increase of 325.04%. The basic earnings per share were 0.08 yuan
